Abstract
GLUT4 upregulation by ALKBH5-mediated m6A demethylation induces glycolysis and resistance to HER2-targeted therapy and represents a potential therapeutic target for treating HER2-positive breast cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have